共 50 条
- [2] Clinical Efficacy and Safety of High-Dose Dexamethasone Plus Low-Dose Rituximab as First-Line Therapy in Newly Diagnosed Primary Immune Thrombocytopenia [J]. Indian Journal of Hematology and Blood Transfusion, 2019, 35 : 507 - 512
- [8] Phase III trial of thalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone in newly diagnosed multiple myeloma [J]. CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (07): : 452 - 453